Invizius announces 'Angry Blood' Haemodialysis Study and recruits its 300th patient

/PRNewswire/ -- Invizius Limited ("Invizius"), a biotechnology company developing second generation therapies for a range of complement-driven autoimmune and...

Related Keywords

Edinburgh ,City Of ,United Kingdom ,Manchester ,Glasgow ,Glasgow City ,Salford ,Scotland ,Jonathan Milner ,Sandip Mitra ,Karolinska Institutet ,Richard Boyd ,Leonard Ebah ,Candy Herbert ,Duha Ilyas ,Edinburgh University Old College Capital ,University Medical Centre Groningen ,Manchester University Hospitals ,University Of Heidelberg ,University Of Manchester ,Prnewswire Invizius Limited ,University Of Strathclyde ,Regulatory Agency ,Foundation Trust ,University Of Oxford ,Angry Blood ,Royal Preston Hospital ,Salford Royal ,Liverpool Royal Infirmary ,Professor Sandip Mitra ,Co Investigators Dr Duha Ilyas ,Manchester Royal Infirmary ,Priming Solution ,Chief Executive Officer ,Chief Technology Officer ,Complement Activation ,Key Opinion Leaders ,Scottish Enterprise ,